Abstract: Novel fluoride and/or deuterium-containing chemical, compounds useful for treating cancer or a related disease or disorder thereof, and pharmaceutical compositions and methods of preparation and use thereof.
Type:
Grant
Filed:
October 2, 2018
Date of Patent:
April 28, 2020
Assignee:
X-CUTAG THERAPEUTICS, INC.
Inventors:
Changfu Cheng, Shuhao Wen, Hui Joyce Li
Abstract: Novel deuterium-containing chemical compounds are provided. They are glucosylceramide (GSC) synthase inhibitors and are useful for treating various types of lysosomal storage diseases including Fabry's disease, Gaucher's disease and Parkinson's disease, or related diseases and conditions. Also described are pharmaceutical compositions, and methods of preparation and use thereof.
Abstract: Novel deuterium-containing chemical compounds are provided. They are glucosylceramide (GSC) synthase inhibitors and are useful for treating various types of lysosomal storage diseases including Fabry's disease, Gaucher's disease and Parkinson's disease, or related diseases and conditions. Also described are pharmaceutical compositions, and methods of preparation and use thereof.
Abstract: Novel fluoride and/or deuterium-containing chemical, compounds useful for treating cancer or a related disease or disorder thereof, and pharmaceutical compositions and methods of preparation and use thereof.
Type:
Application
Filed:
October 2, 2018
Publication date:
June 6, 2019
Applicant:
X-Cutag Therapeutics, Inc.
Inventors:
Changfu CHENG, Shuhao WEN, Hui Joyce LI